BRCA2;
homologous recombination;
DNA repair;
DNA interstrand crosslink;
Rad51;
single-strand annealing;
D O I:
10.1038/sj.onc.1205659
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The BRCA2 tumor suppressor has been implicated in the maintenance of genomic integrity through a function in cellular responses to DNA damage. The BRCA2 protein directly associates with Rad51, that is essential for repair of double-strand breaks (DSBs) by homologous recombination (HR). In this report, we study the BRCA2-defective Chinese hamster cell mutant V-C8 for its ability to perform homology-directed repair (HDR) between repeated sequences. V-C8 cells were recently shown to be defective in Rad51 foci formation in response to DNA damage. Strikingly, we find that these BRCA2 mutant cells exhibit a strong stimulation of HDR activity compared to the V79 parental cells, which harbor a wild-type BRCA2. Furthermore, molecular characterization of the HDR products shows that loss of BRCA2 in V-C8 cells leads to significant reduction in Rad51-dependent gene conversion but strong enhancement of Rad51-independent single-strand annealing (SSA) events frequency. These data imply that, when HDR by conservative gene conversion is impaired, DSBs usually repaired by this pathway are instead resolved by other non-conservative HDR subpathways. Therefore, high chromosomal instability in BRCA2-deficient cells presumably results from enhancement of error-prone repair mechanisms, such as SSA.
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
De Silva, IU
McHugh, PJ
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
McHugh, PJ
Clingen, PH
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
Clingen, PH
Hartley, JA
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
De Silva, IU
McHugh, PJ
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
McHugh, PJ
Clingen, PH
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England
Clingen, PH
Hartley, JA
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, EnglandUCL, Royal Free & Univ Coll Med Sch, Dept Oncol, CRC Drug DNA Interact Res Grp, London W1P 8BT, England